Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood

Clinical trial NCT00923910 · COMPLETED

Trial details

NCT number: NCT00923910
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leukemia, Acute Myelogenous (AML)Leukemia, Acute Lymphocytic (ALL)Leukemia, Chronic Myelogenous (CML)Myelodysplastic Syndrome (MDS)Non-Hodgkin's Lymphoma (NHL)

Start date: 2008-02-22
Primary completion: 2013-10-18
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.